American National Bank & Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4M | Sell |
77,067
-2,059
| -3% | -$443K | 1.66% | 15 |
|
|
2026
Q1 | $17.2M | Sell |
79,126
-119
| -0.2% | -$26.4K | 1.64% | 17 |
|
|
2025
Q4 | $18.1M | Buy |
79,245
+443
| +0.6% | +$101K | 1.71% | 15 |
|
|
2025
Q3 | $18.2M | Sell |
78,802
-1,863
| -2% | -$379K | 1.8% | 12 |
|
|
2025
Q2 | $15M | Buy |
80,665
+2,320
| +3% | +$431K | 1.53% | 15 |
|
|
2025
Q1 | $16.4M | Sell |
78,345
-3,936
| -5% | -$765K | 1.82% | 15 |
|
|
2024
Q4 | $14.6M | Buy |
82,281
+17,545
| +27% | +$3.23M | 1.63% | 16 |
|
|
2024
Q3 | $12.8M | Sell |
64,736
-5,485
| -8% | -$1.02M | 1.51% | 17 |
|
|
2024
Q2 | $12M | Buy |
70,221
+9,013
| +15% | +$1.49M | 1.5% | 16 |
|
|
2024
Q1 | $11.1M | Buy |
61,208
+1,816
| +3% | +$313K | 1.48% | 20 |
|
|
2023
Q4 | $9.2M | Buy |
59,392
+2,695
| +5% | +$393K | 1.45% | 19 |
|
|
2023
Q3 | $8.45M | Buy |
56,697
+2,467
| +5% | +$362K | 1.44% | 20 |
|
|
2023
Q2 | $7.31M | Buy |
54,230
+5,902
| +12% | +$865K | 1.23% | 25 |
|
|
2023
Q1 | $7.7M | Buy |
48,328
+2,319
| +5% | +$355K | 1.42% | 22 |
|
|
2022
Q4 | $7.44M | Sell |
46,009
-563
| -1% | -$86.3K | 1.53% | 20 |
|
|
2022
Q3 | $6.25M | Sell |
46,572
-806
| -2% | -$116K | 1.49% | 23 |
|
|
2022
Q2 | $7.26M | Sell |
47,378
-11,335
| -19% | -$1.73M | 1.73% | 19 |
|
|
2022
Q1 | $9.52M | Buy |
58,713
+193
| +0.3% | +$28K | 1.89% | 17 |
|
|
2021
Q4 | $7.92M | Sell |
58,520
-1,436
| -2% | -$170K | 1.55% | 22 |
|
|
2021
Q3 | $6.47M | Buy |
59,956
+8,360
| +16% | +$955K | 1.43% | 27 |
|
|
2021
Q2 | $5.81M | Sell |
51,596
-4,183
| -7% | -$471K | 1.24% | 34 |
|
|
2021
Q1 | $6.04M | Buy |
55,779
+15,068
| +37% | +$1.61M | 1.42% | 29 |
|
|
2020
Q4 | $4.36M | Buy |
40,711
+38,236
| +1,545% | +$3.67M | 1.13% | 38 |
|
|
2020
Q3 | $217K | Buy |
2,475
+580
| +31% | +$54.6K | 0.06% | 87 |
|
|
2020
Q2 | $186K | Buy |
1,895
+695
| +58% | +$61.2K | 0.06% | 91 |
|
|
2020
Q1 | $91K | Sell |
1,200
-4,034
| -77% | -$344K | 0.04% | 109 |
|
|
2019
Q4 | $463K | Sell |
5,234
-1,741
| -25% | -$145K | 0.14% | 76 |
|
|
2019
Q3 | $528K | Buy |
6,975
+52
| +0.8% | +$3.56K | 0.16% | 72 |
|
|
2019
Q2 | $503K | Buy |
6,923
+45
| +0.7% | +$3.54K | 0.16% | 75 |
|
|
2019
Q1 | $554K | Buy |
6,878
+2,327
| +51% | +$190K | 0.18% | 80 |
|
|
2018
Q4 | $420K | Sell |
4,551
-13
| -0.3% | -$1.14K | 0.15% | 75 |
|
|
2018
Q3 | $432K | Sell |
4,564
-21
| -0.5% | -$1.99K | 0.12% | 90 |
|
|
2018
Q2 | $425K | Buy |
4,585
+14
| +0.3% | +$1.37K | 0.12% | 97 |
|
|
2018
Q1 | $433K | Buy |
4,571
+813
| +22% | +$89.3K | 0.12% | 92 |
|
|
2017
Q4 | $363K | Sell |
3,758
-4,825
| -56% | -$455K | 0.1% | 102 |
|
|
2017
Q3 | $763K | Buy |
8,583
+4,590
| +115% | +$349K | 0.23% | 76 |
|
|
2017
Q2 | $290K | Buy |
3,993
+1,522
| +62% | +$102K | 0.09% | 95 |
|
|
2017
Q1 | $161K | Buy |
2,471
+299
| +14% | +$18.8K | 0.05% | 111 |
|
|
2016
Q4 | $136K | Buy |
2,172
+1,657
| +322% | +$101K | 0.04% | 116 |
|
|
2016
Q3 | $32K | Hold |
515
| – | – | 0.01% | 147 |
|
|
2016
Q2 | $32K | Buy |
+515
| New | +$31.4K | 0.01% | 146 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | – | – | 203 |
|
|
2015
Q4 | $0 | Sell |
1
-64,741
| -100% | -$3.73M | ﹤0.01% | 230 |
|
|
2015
Q3 | $3.52M | Hold |
64,742
| – | – | 1.5% | 23 |
|
|
2015
Q2 | $4.35M | Sell |
64,742
-1,735
| -3% | -$113K | 1.74% | 22 |
|
|
2015
Q1 | $3.89M | Sell |
66,477
-3,437
| -5% | -$208K | 1.51% | 27 |
|
|
2014
Q4 | $4.58M | Sell |
69,914
-813
| -1% | -$51.3K | 1.75% | 22 |
|
|
2014
Q3 | $4.08M | Sell |
70,727
-89
| -0.1% | -$4.94K | 1.58% | 24 |
|
|
2014
Q2 | $4M | Sell |
70,816
-1,067
| -1% | -$56K | 1.5% | 28 |
|
|
2014
Q1 | $3.69M | Sell |
71,883
-178
| -0.2% | -$9K | 1.48% | 31 |
|
|
2013
Q4 | $3.81M | Sell |
72,061
-1,260
| -2% | -$61.9K | 1.52% | 30 |
|
|
2013
Q3 | $3.28M | Sell |
73,321
-102
| -0.1% | -$4.52K | 1.39% | 30 |
|
|
2013
Q2 | $3.04M | Buy |
+73,423
| New | +$3.21M | 1.35% | 30 |
|
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
American National Bank & Trust's ABBV Position: Q2 2026 in Review
American National Bank & Trust reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $443K and leaving 77,067 shares worth $19.4M. The position accounts for 1.66% of the portfolio, ranked #15.
American National Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 1,561 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- American National Bank & Trust held 77,067 shares of AbbVie worth $19.4M as of Q2 2026.
- American National Bank & Trust sold 2,059 AbbVie shares in Q2 2026, an estimated $443K.
- AbbVie made up 1.66% of American National Bank & Trust's portfolio in Q2 2026, its #15 holding.
- American National Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 1,561 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on American National Bank & Trust's 13F filing for Q2 2026, filed 22 Jul 2026.